Robert E. Sievers
Analytical chemistry, pharmaceutical science, aerosols, microparticles and nanoparticles, supercritical fluids, and thin film deposition
Professor - Chemistry and Biochemistry
; Core faculty - Environmental Studies Program
; Fellow - Cooperative Institute for Research in Environmental Sciences
Ph.D. 1960 University of Illinois
Contact
| .(JavaScript must be enabled to view this email address) 303-492-7943 |
Home Page CU-Boulder Environmental Program Chemistry and Biochemistry Cooperative Institute for Research in Environmental Sciences |
ENVS Graduate Program - Secondary Core prior to Fall 2012
More Info
Administration
Director of CU-Boulder Environmental Program.
Research Details
Fundamental and applied studies of the formation of nanoparticle and microparticle aerosols are underway. Carbon dioxide-assisted nebulization provides superior aerosols for various forms of spectroscopy, such as electro-spray ionization, mass spectrometry and atomic absorption. Sievers' students are collaborating with pharmacists and physicians in the University of Colorado Health Sciences Center of Pharmaceutical Biotechnology, to develop new methods for delivery of aerosol particles useful in direct and painless administration of therapeutic drugs by inhalation. The drugs are dissolved or suspended in supercritical fluids, and unusually small aerosol particles are formed by rapid decompression to facilitate delivery of the aerosol particles to the most distal alveoli and to allow rapid uptake by the lungs. Formation of fine aerosols is expected to become increasingly important in the treatment or vaccination against influenza, infections, cystic fibrosis, asthma, and diabetes.
The simultaneous stabilization , drying, and micronization of vaccines, antibodies, proteins, antibiotics, and anti-inflammatory pharmaceuticals and other products of the biotechnology revolution are under study. Two of the fourteen “Grand Challenges” identified by the Gates Foundation and the NIH Foundation as critical to world health are being addressed by the Sievers group: needle-free administration of vaccines (by pulmonary or nasal aerosols), and vaccines that do not need refrigeration for long term storage.
Coatings of many materials can be deposited on complex surfaces and on particles from 70 nm to 30,00 nm by CAN-BD, a process patented by the Sievers group.
October 20 2011
Robert Sievers: Developing a Dried Powder Inhalant Vaccine
March 15 2011
The man fighting measles one breath at a time
February 18 2009
Gov. Ritter Honors Life-Saving Impact of CU-Boulder Inhalable Vacci
January 13 2009
- Announcements -
Thu Oct 24, 2013
Thu Dec 19, 2013
- Events -
Mon Aug 26, 2013
11:00 am
Tue Sep 10, 2013
05:00 pm
- News -
Jun 18, 2013
Blowin’ in the Wind: More and More Sickening Dust
Jun 10, 2013
Amount of dust blown across the West is increasing, says CU-Boulder study
